Area of research
Pathology and Forensic Medicine · Epidemiology
Research interest
Research interests include Medicine, Internal medicine, Single-nucleotide polymorphism, Genome-wide association study, Scleroderma (fungus), and Immunology.
Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
S2k guideline: Diagnosis and therapy of localized scleroderma
S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival
A concept for integrated care pathways for atopic dermatitis—A GA<sup>2</sup>LEN ADCARE initiative
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update
Standardization procedure for flow cytometry data harmonization in prospective multicenter studies
S2k‐Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Mapping and predicting mortality from systemic sclerosis
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group
Update of EULAR recommendations for the treatment of systemic sclerosis
German guidelines for the diagnosis and therapy of localized scleroderma
Brief Report: <i>IRF4</i> Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of Genome‐Wide Association Studies
Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway
Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Identification of <i>IL12RB1</i> as a Novel Systemic Sclerosis Susceptibility Locus
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci
The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis